首页> 外文期刊>Nuclear Medicine Communications >Clinical value of cystatin C and beta-trace protein in glomerular filtration rate in renal transplant cases with stable renal graft functions: Comparison by the 99mTc-DTPA plasma sample method
【24h】

Clinical value of cystatin C and beta-trace protein in glomerular filtration rate in renal transplant cases with stable renal graft functions: Comparison by the 99mTc-DTPA plasma sample method

机译:半胱氨酸蛋白酶抑制剂C和β-痕量蛋白在肾移植功能稳定的肾移植患者肾小球滤过率中的临床价值:与99mTc-DTPA血浆样品法比较

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: The aim of this study was to investigate the value of cystatin C and beta-trace protein (BTP) levels in determination of the glomerular filtration rate (GFR) by accepting the technetium-99m diethylenetriamine pentaacetic acid (Tc-DTPA) method as the gold standard for GFR measurement in renal transplant patients with stable renal functions and to investigate the value of cystatin C and BTP levels in the determination of GFR in cases with or without renal tubular injury. METHODS: A total of 89 (60 men and 29 women) renal transplant patients aged 19-67 years (mean 38.15 years) with stable graft functions were included in the study. GFR was calculated using three different methods: (a) the Tc-DTPA two plasma sample method; (b) eight different formulas containing cystatin C; and (c) three different formulas containing BTP. In addition, the cases were divided into two groups on the basis of N-acetyl-β-D- glucosaminidase and β2 microglobulin levels showing tubular damage. RESULTS: GFR values obtained with cystatin C had a better correlation with the gold standard method compared with those obtained with BTP, and the GFR value obtained with cystatin C had the most reliable consistency. We found that cystatin C provided more accurate results in GFR follow-up in renal transplant patients with no tubular injury compared with those with tubular injury. CONCLUSION: Cystatin C is a good marker of GFR in renal transplant patients, especially in those with no tubular injury; however, BTP is not as good as cystatin C in that regard.
机译:目的:本研究的目的是通过采用99m二乙三胺五乙酸(Tc-DTPA)方法检测半胱氨酸蛋白酶抑制剂C和β痕量蛋白(BTP)在确定肾小球滤过率(GFR)中的价值。肾功能稳定的肾移植患者中GFR测定的金标准,并探讨半胱氨酸蛋白酶抑制剂C和BTP水平在有无肾小管损伤病例中测定GFR的价值。方法:共有89名(60名男性和29名女性)年龄在19-67岁(平均38.15岁)且移植物功能稳定的肾移植患者被纳入研究。使用三种不同的方法计算GFR:(a)Tc-DTPA两种血浆样品法; (b)八种不同的含有胱抑素C的配方; (c)包含BTP的三个不同公式。此外,根据N-乙酰基-β-D-氨基葡萄糖苷酶和显示肾小管损害的β2微球蛋白水平将病例分为两组。结果:与BTP相比,胱抑素C获得的GFR值与金标准方法具有更好的相关性,胱抑素C获得的GFR值具有最可靠的一致性。我们发现,在没有肾小管损伤的肾移植患者中,与肾小管损伤的患者相比,胱抑素C在GFR随访中提供了更准确的结果。结论:胱抑素C是肾移植患者尤其是无肾小管损伤的患者良好的GFR标志物。但是,就这一点而言,BTP不如胱抑素C好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号